Browse our extensive catalog of high-quality chemicals for research and development.
| Product Name | Description | CAS Number | Molecular Formula | Molecular Weight | Description |
|---|---|---|---|---|---|
| rac trans-1,2-Dihydroxy-1,2-dihydronaphthalene-13C4 | (1R,2R)-rel-1,2-Dihydro-1,2-naphthalenediol-13C4; trans-1,2-Naphthalenedihydrodiol-13C4; | C6 13C4H10O2 | 166.16 | (1R,2R)-rel-1,2-Dihydro-1,2-naphthalenediol-13C4; trans-1,2-Naphthalenedihydrodiol-13C4;
| |
| 3-(Difluoromethoxy)picolinic Acid | 1211541-12-6 | C7H5NO3F2 | 189.12 | ||
| Dihydroxy Diketo Atorvastatin Impurity | 5,6-Dideoxy-1-C-(4-fluorophenyl)-5-methyl-2-C-phenyl-3-C-[(phenylamino)carbonyl]-hexos-4-ulose; | 1046118-44-8 | C26H24FNO5 | 449.47 | 5,6-Dideoxy-1-C-(4-fluorophenyl)-5-methyl-2-C-phenyl-3-C-[(phenylamino)carbonyl]-hexos-4-ulose;
|
| N-Hydroxy-7-(4-dimethylaminobenzoyl)aminoheptanamide | 4-(Dimethylamino)-N-[7-(hydroxyamino)-7-oxoheptyl]benzamide; D 237; M 344; M 344 (Enzyme Inhibitor); MS 344; | 251456-60-7 | C16H25N3O3 | 307.39 | 4-(Dimethylamino)-N-[7-(hydroxyamino)-7-oxoheptyl]benzamide; D 237; M 344; M 344 (Enzyme Inhibitor); MS 344;
|
| 10-Hydroxy-9-[(dimethylamino)methyl]-5-ethoxy-(20S,5RS)-camptothecin | (4S)-10-[(Dimethylamino)methyl]-12-ethoxy-4-ethyl-4,9-dihydroxy-1H-pyrano[3,4:6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione | 504413-76-7 | C25H27N3O6 | 465.5 | (4S)-10-[(Dimethylamino)methyl]-12-ethoxy-4-ethyl-4,9-dihydroxy-1H-pyrano[3,4:6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione
|
| 1-[(4-Hydroxy-3,5-dimethylbenzoyl)oxy]-2,5-pyrrolidinedione | 4-Hydroxy-3,5-dimethyl-benzoic Acid 2,5-Dioxo-1-pyrrolidinyl Ester | 158788-56-8 | C13H13NO5 | 263.25 | 4-Hydroxy-3,5-dimethyl-benzoic Acid 2,5-Dioxo-1-pyrrolidinyl Ester
|
| 1,1-(2-Hydroxy-4,6-dimethoxy-1,3-phenylene)bis-1-propanone | 94190-87-1 | C14H18O5 | 266.29 | ||
| 8-Hydroxy-dihydroergocristine | (6aR,9R,10aR)-N-((2R,5S,10aS,10bS)-5-Benzyl-8,10b-dihydroxy-3,6-dioxo-2-propyloctahydro-2H-oxazolo[3,2-a]pyrrolo[2,1-c]pyrazin-2-yl)-7-methyl-4,6,6a,7,8,9,10,10a-octahydroindolo[4,3-fg]quinoline-9-carboxamide | C35H41N5O6 | 627.73 | (6aR,9R,10aR)-N-((2R,5S,10aS,10bS)-5-Benzyl-8,10b-dihydroxy-3,6-dioxo-2-propyloctahydro-2H-oxazolo[3,2-a]pyrrolo[2,1-c]pyrazin-2-yl)-7-methyl-4,6,6a,7... | |
| 5-(4-Hydroxy-3,5-dimethoxybenzyl)-uracil | 5-[(4-Hydroxy-3,5-dimethoxyphenyl)methyl]-2,4(1H,3H)-pyrimidinedione | 21253-60-1 | C13H14N2O5 | 278.26 | 5-[(4-Hydroxy-3,5-dimethoxyphenyl)methyl]-2,4(1H,3H)-pyrimidinedione
|
| 3a-Hydroxy-1,1-dimethyl-5{[(methylamino)sulfonyl]methyl}-1,2,3,3a,8,8a-hexahydropyrrolo[2,3-b]indol-1-ium Trifluoroacetate-d6 | 3a-Hydroxy-1,1-dimethyl-5-((N-methylsulfamoyl)methyl)-1,2,3,3a,8,8a-hexahydropyrrolo[2,3-b]indol-1-ium 2,2,2-trifluoroacetate-d6; Sumatriptan Succinate Impurity 2-d6 | C16H16D6F3N3O5S | 431.46 | 3a-Hydroxy-1,1-dimethyl-5-((N-methylsulfamoyl)methyl)-1,2,3,3a,8,8a-hexahydropyrrolo[2,3-b]indol-1-ium 2,2,2-trifluoroacetate-d6; Sumatriptan Succinat... |
Page 7438 of 10017